Alembic Global Advisors

Chemical Industry Reports

Global Chemicals and E&C: The capital cost conundrum

09/08/14 -

Global Chemicals and E&C – The capital cost conundrum

  • Capital cost inflation should result in ethylene replacement values rising by 1.8x
  • New US facilities economically viable despite inflation; E&C margins to expand
  • AXLL and MEOH most attractively valued; CBI and JEC with highest EPS leverage


With over 11.3m tons of greenfield ethylene capacity having been announced in the US, representing around 21% of incremental capacity through 2017, we believe an analysis of project costs particularly in today’s capital cost inflation environment is key.

Our bottom-up analysis that looks at the various components of project costs – commodity prices, EP&C costs, personnel wages and equipment and facility costs – suggests that greenfield ethylene plants may have experienced a 1.8x inflation over the last decade. This would peg current greenfield ethylene replacement value at around 74c/lb. 

The implications of higher capital costs for the chemical sector can be put into three buckets: (1) impact on commodity profitability, (2) impact on cost curves, and finally (3) impact on project NPV. We see higher capital costs boosting the fixed cost part of ethylene production economics by around 1.9c/lb. Keeping in mind the over 20c/lb cost advantage enjoyed by ethane based ethylene producers in the US we believe higher capital costs will not move the needle much in terms of global cost curves. In terms of project profitability using current economics we see greenfield US-ethane based ethylene facilities generating IRR’s of around 20.5% significantly higher than a WACC of around 10.1% suggesting most of these newly announced facilities are economically viable despite a near doubling in capital costs. Despite these capacity additions we see the ethylene story being a supply dearth one with demand outstripping supply over the next five years and expect a peak in the cycle as early as 2016. From a valuation perspective we see shares of Axiall Corporation and Methanex trading at the steepest discount relative to their replacement value.

From an E&C sector perspective higher capital costs, in our view, should translate to significant margin expansion. Our 2015 margin estimates are still over 200 bps below the last cycle peak, which we believe could prove quite conservative given how quickly capital cost inflation can result in E&C’s gaining pricing power. We see the greatest upside earnings leverage in a margin expansion scenario, relative to our estimates, at JEC, CBI, FLR and KBR in that order.


05/05/14      Industry Note
US Chemicals: Exaggerated ethane exports?

03/31/14      Industry Note
US Chemicals: Seasonal trade not that obvious

03/17/14      Industry Note
US Chemicals: Further consolidation in TiO2 land?

02/03/14      Industry Note
US Chemicals: Ethane price sizzle may soon fizzle

12/23/13      Industry Note
US Chemicals: Identifying the winners for 2014

12/16/13      Industry Note
Global Chemicals: TiO2 recovery well under way

10/14/13      Industry Note
US Chemicals: Justifiable outperformance in Q3'13

09/06/13      Industry Note
Higher C3 pricing here to stay

07/22/13      Industry Note
US Chemicals: Assessing the China impact

04/22/13      Industry Note
US Chemicals: Some valuation perspective

01/14/13       Industry Initiation
US Chemicals: NGL depression could linger

12/31/12      Industry Note
US Chemicals: Identifying the winners for 2013

09/10/12      Industry Note
Global Chemicals – The capital cost conundrum

06/11/12      Company Note
US Chemicals – Sifting through the rubble

05/09/12      Industry Note
Global TiO2 – Ilmenite not a party spoiler

04/16/12      Industry Note
US Chemicals – Consensus bar low for Q1’12

04/02/12      Industry Note
US Chemicals – To risk or de-risk?

01/16/12      Industry Note
US Chemicals – Propylene prices bottoming

01/04/12      Industry Note
MENA Chemicals – Identifying winners for 2012

12/05/11      Industry Note
Global Chemicals – How special are specialties?

10/24/11      Industry Note
US Chemicals – An ethane pricing bubble?

10/18/11      Industry Note
Global Chemicals – Expecting a decent quarter

09/30/11      Industry Note
US Chemicals – Have we hit a floor yet?

07/18/11      Industry Note
US Chemicals – Currency tailwinds ahead?

07/05/11      Industry Note
US Chemicals – Bottoming prices, rising shares?

11/29/10      Industry Note
US Chemicals - A peek at the peak

07/26/10      Industry Note
Secular shifts from shale

07/19/10      Industry Note
Expecting broad based earnings strength in Q2'10

07/12/10    Global Chemicals   
Global Chemicals - Bullish on ethane based economics

06/28/10      Industry Note
US Chemicals: Currency headwinds ahead?

05/25/10    Middle Eastern Chemicals   Industry Note
Sifing through the rubble and finding opportunities

05/18/10    Industry Note   Industry Note
Global Chemicals - The China Effect

05/10/10    US Chemicals   Industry Note
Could the capacity addition wave be a whimper

04/26/10    Industry Note   
Middle Eastern Chemicals

04/19/10    Industry Note   Industry Note
Expecting broad based earnings strength in Q1

03/03/10    Global Chemicals   Industry Note
Chemical Sector M&A

02/24/10    Middle Eastern Chemicals   Industry Note
Mixed feed, mixed economics, mixed sentiment

02/16/10    Industry Note   Industry Note
To LNG or not to LNG

12/16/09       Industry Initiation
Global Chemicals – The time is now!

Copyright 2009 - 2014 Alembic Global Advisors.
All rights reserved | Sitemap
built by

Alembic Global Advisors is an
Institutional Investor Research Boutique.
Not Intended for Retail Investors
Brokerage services offered through JonesTrading Institutional Services

Alembic Global Advisors
780 Third Avenue, 3rd floor
New York, NY 10017